Articles in section Licensing
| << Joint Venture | 502 articles | Mergers & Acquisitions >> |
| << Previous | Pages 1 ..1 2 3 4 5 6 .. 51 | Next >> |
-
MorphoSys Out-licenses Two Oncology Antibodies to HIBio
-
Biogen Licenses Parkinson’s Drug from Alectos Therapeutics for up to US$722.5 M
-
Bristol Myers Squibb Licenses BridgeBio’s BBP-398 for Cancer
-
Jazz Licenses Sumitomo’s Narcolepsy Drug for US$50 M Upfront
-
Sanofi Enters Multi-Billion Dollar Antibody Deals with Adagene and IGM
-
Novartis Delves Further into AAV Gene Therapies with US$1.65 B Voyager Deal
-
Endpoint Health and Grifols Collaborate to Develop Antithrombin III for Sepsis
-
Genmab Licenses Synaffix’s Antibody-Drug Conjugate Technologies
-
AstraZeneca Pays US$200 M Upfront for Ionis’ Rare Disease Drug
-
Astellas Partners with Dyno Therapeutics for Gene Therapy Technology
RSS